Middle East & Africa Radiopharmaceuticals Market Size & Outlook
The radiopharmaceuticals market in Middle East & Africa is expected to reach a projected revenue of US$ 1,392.7 million by 2030. A compound annual growth rate of 10.3% is expected of Middle East & Africa radiopharmaceuticals market from 2025 to 2030.
- Pharmaceuticals
- Radiotherapy/Nuclear Medicine
- Radiopharmaceuticals Market Outlook
- Radiotherapy/Nuclear Medicine
Revenue, 2024 (US$M)
$712.8
Forecast, 2030 (US$M)
$1,392.7
CAGR, 2025 - 2030
10.3%
Report Coverage
Middle East & Africa
Middle East Africa Radiopharmaceuticals Market, 2018-2030 (US$M)
Global Report
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the radiopharmaceuticals market
Every figure cited from GVR research
MEA radiopharmaceuticals market highlights
- The MEA radiopharmaceuticals market generated a revenue of USD 712.8 million in 2024.
- The market is expected to grow at a CAGR of 10.3% from 2025 to 2030.
- In terms of segment, diagnostics was the largest revenue generating product in 2024.
- Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 712.8 million |
| Market revenue in 2030 | USD 1,392.7 million |
| Growth rate | 10.3% (CAGR from 2025 to 2030) |
| Largest segment | Diagnostics |
| Fastest growing segment | Diagnostics |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.0% of the radiopharmaceuticals market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 7,648.3 million by 2030.
No credit card required*
Publish Date: Mar 27, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiopharmaceuticals Market Scope
Radiopharmaceuticals Market segmentation & scope
Product
Diagnostics
Therapeutics
Application
Neurology
Oncology
Lymphoma
Endocrine Tumor
Pulmonary Scans
Urology
Other
Cardiology
Thyroid
Bone Metastasis
End Use
Hospitals
Diagnostic Centers
Others
Radiopharmaceuticals Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Cardinal Health Inc | View profile | 48,000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | www.cardinalhealth.com |
| Ntp Radioisotopes | View profile | 251-500 | Brits, NA - South Africa, South Africa, Africa | www.ntp.co.za/ |
| Covidien | View profile | 10001+ | Dublin, Dublin, Ireland, Europe | www.covidien.com |
| Positron Corp | View profile | 19 | 1777 Maryland Avenue, Niagara Falls, NY, United States, 14305 | www.positron.com |
| GE Healthcare | View profile | 10001+ | Chicago, Illinois, United States, North America | www.gehealthcare.com |
| Lantheus Medical Imaging, Inc. | View profile | - | - | - |
Middle East & Africa Radiopharmaceuticals Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Radiopharmaceuticals Market Outlook will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 91.98% in 2024.
Horizon Databook has segmented the Middle East & Africa radiopharmaceuticals market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
- Middle East & Africa Radiopharmaceuticals Market Product Outlook (Revenue, USD Million , 2018-2030)
- Diagnostics
- Therapeutics
- Middle East & Africa Radiopharmaceuticals Market Application Outlook (Revenue, USD Million , 2018-2030)
- Neurology
- Oncology
- Lymphoma
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Thyroid
- Bone Metastasis
- Middle East & Africa Radiopharmaceuticals Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Hospitals
- Diagnostic Centers
- Others
Reasons to subscribe to Radiopharmaceuticals Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Radiopharmaceuticals Market Outlook databook
- Our clientele includes a mix of Radiopharmaceuticals Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Radiopharmaceuticals Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Radiopharmaceuticals Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Middle East Africa Radiopharmaceuticals Market, 2018-2030 (US$M)
MEA radiopharmaceuticals market statistics, by product, 2018-2030 (US$M)
